IP Library Granted Patent US 9,314,290
Granted Patent B2
US 9,314,290 · App. 13/741,360 · Granted Apr 19, 2016

Cryogenic needle with freeze zone regulation

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,314,290
App. No.
13/741,360
Granted
Apr 19, 2016
Kind
B2
Abstract

A cryogenic needle of a cryogenic system is coupled to a heater. While the needle is inserted into target tissue beneath skin, the heater provides heat to protect the skin. Power supplied to the heater is used to interpolate performance of the needle and/or operating parameters of the cryogenic system.

Claims (47)

1. A method for cryogenically treating tissue, the method comprising:

regulating coolant to a needle probe using a valve, the needle probe having at least one needle and a heater thermally coupled to the at least one needle, wherein the heater comprises a thermally conductive element, the thermally conductive element being thermally coupled to a proximal skin engaging portion of the at least one needle;

providing power to the heater based on power demand from the heater;

monitoring the power provided to the heater; and

performing a correlation of the monitored power with at least one of a tissue characteristic and/or an operating parameter.

2. The method of claim 1 , further comprising actuating the valve to provide more or less of the coolant to the needle probe based on the at least one of the correlated tissue characteristic and-or the operating parameter.

3. The method of claim 1 , wherein the power demand is based on maintaining the heater at a particular temperature.

4. The method of claim 1 , further comprising monitoring a temperature of the thermally conductive element.

5. The method of claim 1 , further comprising providing a user indication based on the correlation of the monitored power with the at least one of the tissue characteristic and-or the operating parameter.

6. The method of claim 5 , wherein the user indication comprises a tissue type.

7. The method of claim 5 , wherein the correlation is performed of the monitored power with the operating parameter, wherein the operating parameter indicates malfunction of the valve.

8. The method of claim 7 , further comprising providing a user alert based on the malfunction.

9. The method of claim 1 , wherein regulating the coolant comprises operating the valve to provide the coolant to the needle probe for a predetermined period of time.

10. The method of claim 1 , wherein the correlation is performed with the operating parameter, wherein the operating parameter comprises at least one of a heat transfer rate, a heat flux, a temperature change rate, and/or a temperature differential.

11. A method for cryogenically treating tissue, the method comprising:

regulating coolant to a needle probe using a valve, the needle probe having at least one needle and a heater thermally coupled to the at least one needle, wherein the at least one needle comprises a sensorless needle;

providing power to the heater based on power demand from the heater;

monitoring the power provided to the heater; and

performing a correlation of the monitored power with at least one of a tissue characteristic and/or an operating parameter.

12. The method of claim 11 , wherein the sensorless needle is 25 gauge or smaller.

13. A method for cryogenically treating tissue, the method comprising:

regulating coolant to a needle probe using a valve, the needle probe having at least one needle and a heater thermally coupled to the at least one needle;

providing power to the heater based on power demand from the heater;

monitoring the power provided to the heater;

performing a correlation of the monitored power with at least one of a tissue characteristic and an operating parameter; and/or

providing a user indication based on the correlation of the monitored power with the at least one of the tissue characteristic and/or the operating parameter, wherein the user indication comprises needle probe status.

14. A method for cryogenically treating tissue, the method comprising:

regulating coolant to a needle probe using a valve, the needle probe having at least one needle and a heater thermally coupled to the at least one needle;

providing power to the heater based on power demand from the heater;

monitoring the power provided to the heater;

performing a correlation of the monitored power with at least one of a tissue characteristic, an operating parameter, and/or depth of insertion of the at least one needle, wherein the tissue characteristic comprises tissue type.

15. The method of claim 14 , further comprising actuating the valve to provide more or less of the coolant to the needle probe based on the at least one of the correlated tissue characteristics, the operating parameter and/or the depth of insertion of the at least one needle.

16. The method of claim 14 , wherein the power demand is based on maintaining the heater at a particular temperature.

17. The method of claim 14 , wherein the heater comprises a thermally conductive element, the thermally conductive element being thermally coupled to a proximal skin engaging portion of the at least one needle.

18. The method of claim 14 , further comprising monitoring a temperature of a thermally conductive element coupled to the heater.

19. The method of claim 14 , wherein the at least one needle comprises a sensorless needle.

20. The method of claim 14 , further comprising providing a user indication based on the correlation of the monitored power with the at least one of the tissue characteristic, the operating parameter, and/or the depth of insertion of the at least one needle.

21. The method of claim 20 , wherein the user indication comprises the tissue type or a needle probe status.

22. The method of claim 20 , wherein the correlation is performed of the monitored power with the operating parameter, wherein the operating parameter indicates malfunction of the valve.

23. The method of claim 22 , further comprising providing a user alert based on the malfunction.

24. The method of claim 14 , wherein regulating the coolant comprises operating the valve to provide the coolant to the needle probe for a predetermined period of time.

25. The method of claim 14 , wherein the correlation is performed with the operating parameter, wherein the operating parameter comprises at least one of a heat transfer rate, a heat flux, a temperature change rate, and/or a temperature differential.

26. The method of claim 14 , wherein regulating the coolant forms a cooling zone in a target tissue and providing the power to the heater protects a non-target tissue, the method further comprising metering the coolant to the needle probe using the valve based on a correlation of the monitored power, such that the cooling zone is substantially maintained within an allowable size tolerance.

27. The method of claim 26 , wherein metering the coolant comprises regulating the valve to halt or decrease the coolant flowing in the needle probe long enough for the cooling zone to decrease in size within the allowable size tolerance.

28. The method of claim 26 , wherein metering the coolant comprises regulating the valve to increase the coolant flowing in the needle probe long enough for the cooling zone to increase in size within the allowable size tolerance.

29. The method of claim 26 , wherein the allowable size tolerance is determined by performing a tissue pre-characterization routine using the needle probe.

30. The method of claim 26 , wherein regulating the coolant is based on a predetermined treatment algorithm.

Assignments (9)
RELEASE OF SECURITY INTEREST Recorded Dec 5, 2025
From: JPMORGAN CHASE BANK, N.A.
To: PACIRA CRYOTECH, INC.; PACIRA PHARMACEUTICALS, INC.; PACIRA THERAPEUTICS, INC. (F/K/A FLEXION THERAPEUTICS, INC.)
Reel/Frame 073779/0532 →
CONFIRMATORY GRANT OF SECURITY INTEREST IN UNITED STATES PATENTS Recorded Mar 31, 2023
From: PACIRA CRYOTECH, INC.; PACIRA PHARMACEUTICALS, INC.; PACIRA THERAPEUTICS, INC. (F/K/A FLEXION THERAPEUTICS, INC.)
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 063214/0108 →
TERMINATION AND RELEASE OF SECURITY INTEREST IN PATENTS Recorded Mar 31, 2023
From: JPMORGAN CHASE BANK, N.A.
To: PACIRA CRYOTECH, INC.; PACIRA PHARMACEUTICALS, INC.; PACIRA THERAPEUTICS, INC. (F/K/A FLEXION THERAPEUTICS, INC.)
Reel/Frame 063213/0864 →
SUPPLEMENTAL CONFIRMATORY GRANT OF SECURITY INTEREST IN UNITED STATES PATENTS Recorded Dec 14, 2021
From: PACIRA CRYOTECH, INC.; PACIRA PHARMACEUTICALS, INC.; FLEXION THERAPEUTICS, INC.
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 058516/0636 →
CONFIRMATORY ASSIGNMENT Recorded Jul 15, 2019
From: MYOSCIENCE, INC.
To: PACIRA CRYOTECH, INC.
Reel/Frame 049758/0028 →
RELEASE OF SECURITY INTEREST Recorded Feb 4, 2019
From: VENTURE LENDING & LEASING VII, INC.
To: MYOSCIENCE, INC.
Reel/Frame 048237/0168 →
CORRECTIVE ASSIGNMENT TO CORRECT TO REMOVE APPLICATION NUMBER 12160639 PREVIOUSLY RECORDED AT REEL: 034557 FRAME: 0073. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY AGREEMENT. Recorded Dec 29, 2014
From: MYOSCIENCE, INC.
To: VENTURE LENDING & LEASING VII, INC.
Reel/Frame 034713/0226 →
SECURITY INTEREST Recorded Dec 19, 2014
From: MYOSCIENCE, INC.
To: VENTURE LENDING & LEASING VII, INC.
Reel/Frame 034557/0073 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 29, 2013
From: FOURKAS, MICHAEL; WILLIAMS, RONALD; ALLISON, JOHN; ROSEN, JESSE
To: MYOSCIENCE, INC.
Reel/Frame 030503/0300 →